Cystic Fibrosis Screening

Cystic Fibrosis Screening

It is a highly multiplexed panel for screening clinically significant 72 common mutations in the CFTR gene. This panel also includes 5T variant which is a common mild variant occurring in 1 in 10 individuals in the general population.

Please Contact us for more details.

Cystic Fibrosis Screening
Cystic Fibrosis Screening
What it screens?

It is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects).

LEARN MORE

The below table shows a list of 72 common CFTR mutationsincluded in the Panel in which 23 are ACMG/ACOG recommended mutations and the other 49 are the most common variants with known relevance.

Cystic Fibrosis Screening
Who should be screened ?

Patients with positive sweat test results. Infant or child presenting with symptoms like diarrhea, malnutrition, poor growth, and weight loss.

LEARN MORE

  • Individuals with symptoms like chronic coughing, wheezing, and inflammation
  • Abnormal prenatal ultrasound findings (like hyperechogenic fetal bowel) during routine pregnancy tests.
  • Any carrier or CF affected individual in family.
  • Male Parent presentingsymptoms of infertility.
  • Couples who are married within family
Cystic Fibrosis Screening
Cystic Fibrosis Screening

Complete insight into your health today, bridged with the answers for Tomorrow

Cystic Fibrosis Screening
Benefits
Cystic Fibrosis Screening

FREE Sample Collection

Cystic Fibrosis Screening

PAN India Logistics

Cystic Fibrosis Screening

Accurate Reporting

Cystic Fibrosis Screening

Fast TAT

Cystic Fibrosis Screening

Stringent QC

ibrandox